Source comparison
Peptides for Addiction Recovery: Active vs Investigational Comparison
Selank GABAergic modulation; reduces withdrawal anxiety Preclinical only (rodent models) Research-grade only Promising anxiolytic profile in alcohol withdrawal models. No human addiction trials exist Semax Dopamine turnover enhancement; neuroprotection Preclin
This comparison does not assign a generated winner or score.
- Selank
- GABAergic modulation; reduces withdrawal anxiety
- Preclinical only (rodent models)
- Research-grade only
- Promising anxiolytic profile in alcohol withdrawal models. No human addiction trials exist
- Semax
- Dopamine turnover enhancement; neuroprotection
- Preclinical only (stimulant models)
- Mechanistically relevant to stimulant recovery. Requires Phase II trials before clinical use
- Cerebrolysin
- BDNF upregulation; neuroplasticity support
- Clinical trials in TBI/stroke; none in addiction
- Prescription in select countries; research-grade
- Most studied peptide for neurological recovery. Addiction application remains speculative
- Dihexa
- HGF mimetic; synaptogenesis
- Preclinical cognitive models only
- Potent cognitive enhancer in animal models. Zero human addiction data; safety profile unknown